Abbott Xience Alpine Drug Eluting Stent

The Xience™ Des Is Proven To Offer Unparalleled Patient Outcomes During And Long After Percutaneous Coronary Interventions (Pci).1 With Over 20 Million Implants And Studied In 120+ Clinical Trials,* Xience™ Stent Provides Consistent Long-term Safety Data Beyond 10 Years.2 Xience™ Stent Allows Interventional Cardiologists (Ics) To Achieve The Positive Outcomes They Want For Their Patients. About the Company Legal Status of Firm: Proprietorship Number of Employees: Upto 10 People Annual Turnover: 40 L - 1.5 Cr company-description: Acerbic Inc - Wholesale Trader Of Guide Wire, Cardiology Products And Cardiology Equipment Since 2021 In New Delhi, Delhi.